1. Introduction {#s0010}
===============

Charcot--Marie--Tooth neuropathy (CMT) represents a widely heterogeneous group of disorders with a broad spectrum of clinical and electrophysiological features. More than 80 genes have been identified so far as responsible for CMT, including dominant, recessive and X-linked forms [@bib0010].

CMT type 4B1 (CMT4B1) is an autosomal recessive (AR) motor and sensory demyelinating neuropathy characterized by the association of early-onset neurological symptoms and typical biopsy findings. The histopathological hallmark is the presence of myelin outfoldings in the nerve, redundant and irregular loops of myelin around the axon [@bib0015]. The disease is caused by loss-of-function mutations in the Myotubularin-related 2 gene (*MTMR2*) on chromosome 11q22 [@bib0020].

To date, few cases have been reported and further clarification of the different phenotypes associated with this gene is needed, particularly in consideration of the poor knowledge on the natural history of the disease and its severe course, which may need to provide clinical warnings to care-givers.

We here report the case of a patient with a novel mutation in the *MTMR2* gene, who started to experience stridor and was diagnosed with bilateral vocal cord paralysis at the age of 18 months.

2. Case report {#s0015}
==============

2.1. Clinical and electrophysiological phenotype {#s0020}
------------------------------------------------

The proband is a Pakistani girl born to consanguineous parents (first cousins) after uneventful pregnancy (February 2013). Pes planus was present at birth and she started to walk unaided at 16 months. In the family history, a first-degree cousin experienced early walking difficulties and hoarseness, and died at age of 9 years of respiratory failure, while still ambulant \[Pedigree is reported in [Fig. 1](#f0010){ref-type="fig"}\].

Our patient underwent orthopedic assessment at the age of 12 months and was then evaluated by a neurologist at 18 months. Neurological examination revealed bilateral facial weakness, reduced limb tone, muscle wasting prevalent in lower limbs, absence of tendon reflexes, proximal and distal weakness prevalent in lower limbs, hoarseness and inspiratory stridor. No palpable nerves were noted. Electrophysiological studies performed at 25 months revealed severe motor-sensory demyelinating neuropathy with secondary axonal loss \[Ulnar nerve motor conduction velocity (CV) 27.1 m/s, CMAP 2 mV; Peroneal nerve motor CV 17.3 m/s, CMAP 0.4 mV; Median nerve sensory CV 19.4 m/s, SAP 2.8 µV; Sural nerve SAP not evocable\].

In the following months neurological symptoms did not significantly evolve but the patient continued to present labored respiration with mild stridor. In January 2015 she underwent examination of the larynx by flexible videolaryngoscopy. The exam revealed left vocal cord palsy with right-sided hypomobility. Due to potential complication related to vocal cord paralysis, including respiratory insufficiency with possible aspiration and bronchopneumonia, the patient was considered a candidate for tracheostomy. However, considering the lack of progression of laryngeal symptoms in the following year and the presence of a normal polysomnography performed at 32 months \[Oxygen desaturation events index (n°/h): 0.8. Minimum SatO~2~% value: 90, Mean SatO~2~% value: 94\], surgical intervention was not performed and a regular follow-up was scheduled. Her laryngeal motility disorder was monitored by flexible videolaryngoscopies performed at intervals of 3--4 months. A progressive respiratory deterioration was observed with constant stridor for every minimal effort, activation of accessory respiratory muscles and inspiratory chest retractions, restlessness and difficulties during feeding. At the age of 3 years and 4 months a complete bilateral laryngeal paralysis was observed, with vocal cords in adduction and a respiratory space of about 1 mm. The parents refused surgical treatment at that time. At the age of 3 years and 7 months, due to worsening of clinical symptoms after an upper airway infection with severe respiratory obstruction, the patient required treatment in the Intensive Care Unit. Before admission the child was still able to walk unassisted with bilateral foot-drop and in the previous weeks she had started to present occasional dysphagia for both liquid and solid food. Muscle strength measured by MRC was 3--4 proximally in upper and lower limbs, 1--2 in the anterior tibialis and peroneus muscles. First, we performed glottic enlargement by direct microlaryngoscopy as an attempt to avoid permanent tracheotomy. After deep sedation, the vocal cords widely opened suggesting that the activity of vocal cords adductor muscles was a possible co-factor of the severe glottic obstruction. After incision of the mucosal surface of the posterior right vocal cord by CO~2~ laser, we partially vaporized the vocal muscle. Then, we placed two endo-extralaryngeal sutures by Lichtenberger needle carrier [@bib0025] in order to achieve lateralization of the posterior third of the vocal cord and to obtain closure of the cordotomy wound. We obtained the widening of the glottic space and extubated the child, who showed progressive respiratory improvement. A week after first surgery, the patient underwent tracheotomy as stridor had fully recurred and severe respiratory effort was persisting. Videolaryngoscopy showed the recurrence of glottic obstruction due to active adduction of the arytenoids during the whole respiratory cycle. After tracheotomy the child showed a general health improvement and resumed oral feeding.

2.2. Nerve biopsy and molecular findings {#s0025}
----------------------------------------

Sequencing analysis was initially performed in the *GDAP1* gene, responsible for autosomal recessive CMT4A and frequently associated with vocal cord paresis and stridor. As no mutations were detected, sural nerve biopsy was carried out at 20 months of age. Morphological analysis revealed reduced fiber number, several fibers with reduced myelin thickness, rare onion bulbs and the presence of abundant myelin outfoldings ([Fig. 1](#f0010){ref-type="fig"}), which are a hallmark of CMT4B neuropathy. Given the early onset of the neuropathy, *MTMR2* was first analyzed by performing Sanger sequencing analysis and a novel nonsense mutation in exon 6c.484 C\>T; p.Arg162\* was found. Consistent with an autosomal recessive inheritance, this mutation was present in homozygosity in the proband whereas unaffected parents were both heterozygous carriers of the mutation. This variant was not reported in the SNP database (dbSNP build 132, <http://www.ncbi.nlm.nih.gov/projects/SNP>) or in 1000 Genomes ([www.1000genomes.org](http://www.1000genomes.org){#iw0015}). The premature truncation of the MTMR2 protein at codon 162 leads to the deletion of part of the RID domain, the entire PTP-like phosphatase domain and the CC (coiled-coil) C-terminal motif [@bib0030], [@bib0035]. Moreover, mutations in the *MTMR13* gene responsible for CMT4B2, a severe early onset demyelinating neuropathy also characterized by myelin outfoldings in the nerve, were excluded in the proband as well.

3. Discussion {#s0030}
=============

ARCMTs are usually associated with more severe phenotypes as compared to dominant forms [@bib0040]. Along with motor and sensory defects, they usually present earlier onset and more marked distal limb deformities, sometimes associated with major spinal abnormalities and other complications. Among CMT-associated complications, vocal cord paralysis is still an underestimated finding. Vocal cord paralysis has been reported as an early, severe and frequent symptom of GDAP1-associated neuropathy \[CMT4A\], often followed by diaphragmatic dysfunction [@bib0045], [@bib0050], [@bib0055], [@bib0060], [@bib0065], [@bib0070], and in both AD and AR forms of CMT2A (mutations in the *MFN2* gene) [@bib0075], [@bib0080]. Few cases are reported in axonal dominant CMT2C (mutations in the transient receptor potential cation channel, subfamily V, member 4; *TRPV4*) [@bib0085], [@bib0090], [@bib0095] and as a later involvement in a patient harboring a dominant heterozygous mutation of early growth response 2 (*EGR2*) gene [@bib0100]. Rarely, it has been associated with other variants and polymorphisms [@bib0105], [@bib0110], [@bib0115], [@bib0120], [@bib0125].

An overview of all previously reported cases with early onset in life is provided in [Table 1](#t0010){ref-type="table"}.

Regarding CMT4B1, vocal cord paralysis was reported in one Italian patient, one English patient, and three Algerian siblings by Sabatelli [@bib0130], Tyson and Houlden [@bib0135], [@bib0140] and Nouioua [@bib0145], respectively. All of the patients suffered from early-onset (1--2 years-old) severe demyelinating neuropathy associated with respiratory difficulties. The Algerian siblings presented prominent chest deformities possibly secondary to breathing impairment. In the latter cases sequencing analysis revealed mutations located in exon 4 (c.G308A; p.Gly103Glu and c.331dupA; p.Arg111LysfsX24, respectively). Notably, laryngeal involvement was present in early stages of the disease in all cases.

In our patient, vocal cord paralysis presented as an early symptom, as the onset was between 1 and 2 years of age. The vocal cord disease manifested as a hoarse voice and stridor, associated with the use of accessory inspiratory muscles. An asymmetric involvement of vocal cords was initially noticed with a more severe paralysis of the left cord. This finding was present in previous reports [@bib0045], [@bib0105] and it has been interpreted as a sign of length-dependent degeneration of the neuropathy. However, initial paralysis of the right vocal cord is reported as well and usually a progression toward bilateral deficit is observed. Most of the genes involved in vocal cord paralysis encode for proteins playing a role also in neurons. We may speculate that vocal cord paralysis results from neuronal dysfunction in the bulbar nucleus of the recurrent nerve, rather than a consequence of a length-dependent neuropathy. This might also explain why only few CMT subtypes develop this complication and why no clear correlation with the severity of neuropathy is observed.

To our knowledge, no progression to respiratory failure was seen in previously reported cases. The patient reported by Tyson and colleagues, when aged 16, began to develop frequent chest infections and nocturnal hypoventilation. He was started on a nighttime BIPAP facial mask ventilator with resolution of symptoms. Nevertheless, as shown by our proposita, progressive laryngeal involvement may cause life-threatening airway obstruction, aspiration and pneumonia. Decreased life expectancy and premature death, which was previously described in other forms of CMT [@bib0030], [@bib0045], was observed also in our patient\'s first cousin, who was likely to harbor the same gene mutation (see genetic pedigree) and died of sudden death due to upper airway involvement at the age of 9, while he was still able to walk unaided.

In conclusion, we suggest that the finding of bilateral laryngeal paralysis or hypomotility due to unknown causes should prompt a warning for a neuromuscular disorder, notably a hereditary neuropathy, and help the physician to target molecular investigations. Particularly, we feel that laryngeal involvement might be a relevant and initial finding inearly-onset CMT4B1 neuropathy and thus all the patients with positive molecular genetics for *MTMR2* should be promptly investigated for laryngeal function. Periodic videolaryngoscopic follow-up is mandatory in patients with a CMT subtype associated with vocal cord paralysis in order to detect possible vocal cord hypomotility and to quantify the degree of airway obstruction. It is known that a young child can tolerate without symptoms a laryngotracheal obstruction up to 70% of the lumen, and that a slowly progressing obstruction may manifest with moderate stridor up to 80% or more [@bib0150]. Nevertheless, in such a clinical condition even a mild upper airway infection might have lethal consequences. Severe chest retractions, failure to thrive, refusal of food and no interest in playing might all be the signs of a critical condition which might rapidly precipitate [@bib0150]. Parents of the child should be made aware of their child condition in order to seek for hospital assistance as soon as they notice worsening of respiratory distress. In the described case, a first attempt to achieve a wider glottic space was performed by a vocal cord laterofixation procedure; this is a conservative mean of widening the posterior glottis respecting both phonatory and sphincteric functions of the larynx. Nevertheless, this procedure did not work in our patient, possibly due to the neuropathy as pathogenic mechanism of the vocal cord paralysis. Moreover, this case showed the role of active contraction of vocal cord adductor muscles as a cause of laryngeal obstruction in CMT patients. Tracheotomy appears then to be a necessary procedure to relieve the respiratory distress in patients affected by bilateral laryngeal paralysis in CMT.
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![Molecular analysis and nerve biopsy. (a) Pedigree of the reported family with two affected individuals, first cousins. (b) Electropherograms of exon 6 of the *MTMR2* gene show that the c.484 C\>T (p.Arg162\*) mutation is present in heterozygosity in the unaffected parents and in homozygosity in the proband (IV, 5). The asterisk in the electropherograms indicates the mutation. (c) Sural nerve biopsy of the proband revealed the presence of fibers with outfoldings, infoldings and with redundant basal lamina (arrow). Bar is 1 µm.](nmd3321-fig-0001){#f0010}

###### 

Clinical reports of CMT cases associated with laryngeal involvement in the first 2 decades.

Table 1

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference                            Gender/number of patients (age)          Country of origin             Age of walking (months)   Age of onset   Age of VF involvement      Cranial nerve involvement                                    Other peculiar features                                                                                                         Loss of ambulation (age)     Gene       CMT type, mode of inheritance
  ------------------------------------ ---------------------------------------- ----------------------------- ------------------------- -------------- -------------------------- ------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------- ---------------------------- ---------- ------------------------------------------------------------------
  Present case                         F/1 (3y)                                 Pakistan                      16                        12--18m        18m                        Bilateral facial paresis, mild dysphagia                     Pes planus                                                                                                                      Still walking                MTMR2      CMT4B1, AR

  Sabatelli et al., 1994\              F/1 (28y)                                Italy                         13                        14--15m        15m                        Dysphagia, weakness of masticatory muscles, facial paresis   NA                                                                                                                              22y                          MTMR2      CMT4B1, AR
  Luigetti et al., 2013                                                                                                                                                                                                                                                                                                                                                                                                

  Tyson et al., 1997                   M/1 (16y)                                England                       13                        13--36m        36m                        Difficulty with phonation, chewing, swallowing               Diaphragm paresis                                                                                                               16y                          MTMR2      CMT4B1, AR

  Nouioua et al., 2011                 M/3 (8-16y)                              Algeria                       NA                        1--2y          Stridor present at onset   Facial paresis                                               Chest deformities +++ Breathing difficulties. Pes equinovarus, claw hands                                                       Still walking                MTMR2      CMT4B1, AR

  Dyck et al., 1994                    F/2 (26-47y)                             NA                            NA                        6--8m          6-8m                       Congenital III cranial nerve palsy                           Short stature, diaphragm paresis                                                                                                NA                           TRPV4      CMT2C, AD

  Chen et al., 2010                    F/3 (44-73y); M/1 (29y)                  Non-Hispanic white American   NA                        1--10y         1-10y                      NA                                                           Short stature, diaphragm paresis                                                                                                NA                           TRPV4      CMT2C, AD

  Echaniz-Laguna et al., 2014          M/10; F/7                                France, Italy, Greece         NA                        Childhood      NA                         Hearing loss                                                 Kyphoscoliosis, hyperCKemia, scapular winging, respiratory insufficiency, skeletal dysplasia, arthrogryposis, postural tremor   Still walking                TRPV4      CMT2C; CSMAA; dHMN ; SPSMA; AD -- de novo -incomplete penetrance

  Borkoel et al., 2003                 F/1 (34y); M/1 (64y)                     Japan; Costa Rica             15; 36                    2y; 6m         NA                         Facial paresis; dysphagia                                    NA                                                                                                                              NA                           GDAP1      CMT4A, AR

  Sevilla et al., 2003                 M/8; F/1 (33-57y)                        France                        12--18                    Birth--2y      late                       NA                                                           NA                                                                                                                              9y; 12y; 30y                 GDAP1      CMT4A, AR

  Azzedine et al., 2003                M/1 (30y)                                Morocco                       Normal                    3y             20y                        NA                                                           Paralysis of one hemi diaphragm                                                                                                 15y                          GDAP1      CMT4A, AR

  Stojkovic et al., 2004               F/2 (32-33y)                             France                        20                        \<2 y          early in life              NA                                                           Diaphragm paresis                                                                                                               25y                          GDAP1      CMT4A, AR

  Sevilla et al, 2008                  M/6; F/3 (16-49y)                        Spain                         12--18                    \<1y--8y       NA                         Bilateral facial weakness (n° 1); dysphagia (n° 1)           Diaphragm paresis                                                                                                               9- 38y (median 16)           GDAP1      CMT4A, AR

  Moroni et al., 2009                  M/1 (16y); F/1 (11y)                     Italy                         12--18                    2y             13y                        NA                                                           NA                                                                                                                              12y; still walking           GDAP1      CMT4A, AR

  McEntagart et al., 2001 [@bib9000]   M/13; F/8                                Wales                         NA                        2nd decade     2nd decade                 NA                                                           Distal muscular atrophy                                                                                                         NA                           Dynactin   dHMN-VII, AD

  Polke et al., 2011                   F/1 (39y)                                Italy                         NA                        3y             NA                         Severe facial weakness, hearing loss, visual loss            Kyphoscoliosis, respiratory muscles weakness                                                                                    Wheelchair (age not known)   MFN2       CMT2, AR

  Bombelli et al., 2014                6                                        NA                            NA                        Early onset    NA                         NA                                                           Severe disability (5/6)                                                                                                         NA                           MFN2       CMT2, AD

  Pehlivan et al., 2015 [@bib9005]     M/1 ([†](#sp0030){ref-type="fn"} 33 m)   Turkey                        Not acquired              \<6m           \<6m                       NA                                                           Lateral knee contractures,\                                                                                                     NA                           TRIM2      AR
                                                                                                                                                                                                                                               hammer toes, pes equinus and pes cavus                                                                                                                                  
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: AD, autosomal dominant; AR, autosomal recessive; CMT, Charcot--Marie--Tooth; CSMAA, congenital spinal muscular atrophy and arthrogryposis; dHMN, distal hereditary motor neuropathy; F, female; GDAP1, ganglioside-induced differentiation-associated protein 1; m, months; M, male; MFN2, mitofusin-2; MTMR2, myotubularin related protein 2; NA: data not available; SPSMA, scapula-peroneal spinal muscular atrophy; TRIM2, tripartite motif containing 2; TRPV4, transient receptor potential cation channel subfamily V member 4; VF, vocal fold; y, years; †, died.
